Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants

Fundamental and Clinical Pharmacology

Volumn 23, Issue 2, 2009, Pages 197-205

  Jain, Nishtha ^a   Naseem, Imrana ^a   Ahmad, Jamal ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Comet assay; DNA damage; Metabolic syndrome; Serum paraoxonase 1; Small dense low density lipoprotein

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA DAMAGE; GLUCOSE BLOOD LEVEL; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; COMET ASSAY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DNA DAMAGE; LIPID PEROXIDATION; LYMPHOCYTES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RABBITS; VITAMIN E;

EID: 62849129058     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00666.x     Document Type: Article

References (40)

1. Genuth S., Alberti K.G., Bennett P. Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 26 3160 3167.
2. - radical generation by xanthine oxidase system of pancreatic β cells. FEBS Lett. (1988) 239 295 298.
3. Lima P.H.O., Sinzato Y.K., da Silva Soares de Souza M. et al. Evaluation of level of DNA damage in blood leucocytes of non-diabetic and diabetic rat exposed to cigarette smoke. Mutat. Res. (2007) 628 117 122.
4. Hong J.H., Kim M.J., Park M.R., Kwag O.G., Lee I.S., Byun B.H. Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin. Chim. Acta. (2004) 340 107 115.
5. Harris A., Devaraj S., Jialal I. Oxidative stress, alpha-tocopherol therapy and atherosclerosis. Curr. Atheroscler. Rep. (2002) 4 373 380.
6. Kartal N.O., Negis Y., Aytan N. Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: role of vitamin E. Biofactors (2003) 19 63 70.
7. Frei B., Stocker R., England L., Ames B.N. Ascorbate: the most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. (1990) 264 155 163.
8. Sokoloff B., Hori M., Saelhof C., McConnell B., Imai T. Effect of ascorbic acid on certain blood fat metabolism factors in animals and man. J. Nutrition. (1967) 91 107 118. PubMed
9. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodialation in patients with non-insulin dependent diabetes mellitus. J. Clin. Invest. (1996) 97 22 28.
10. Garin M.C.B., Kalix B., Morabia A., James R.W. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J. Clin. Endocrinol. Metab. (2005) 90 2264 2269.
11. La Du B.N. Human serum paraoxonase/arylesterase, in : Kalow W. (Ed Pharmacogenetics of Drug Metabolism, Pergamon Press, New York, 1992, pp. 51 91.
12. Furlong C.E., Li W.F., Costa L.G., Richter R.J., Shih D.M., Lusis A.J. Genetically determined susceptibility to organophosphorous insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism. Neurotoxicology (1998) 19 645 650.
13. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation (2003) 107 391 397. PubMed.
14. Hannon-Fletcher M.P.A., Kane M.J.O., Moles K.W., Weatherup C., Barnett C.R., Barnett Y.A. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat. Res. (2000) 460 53 60.
15. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. (1969) 6 24 27.
16. Keaney J.F. Jr., Guo Y., Cunningham D., Shwaery G.T., Xu A., Vita J.A. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J. Clin. Invest. (1996) 98 386 394.
17. Singh P.N., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. (1988) 175 184 191.
18. Pearson T.A., Mensah G.A., Alexander R.W. et al. Workshop on Inflammatory markers, and Cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centre for Disease Control and Prevention and the American Heart Association. Circulation (2003) 107 499 511. PubMed
19. Hirano T., Ito Y., Saegura H., Yoshino G. A novel and simple method for quantification of small dense low-density lipoprotein. J. Lipid Res. (2003) 44 2193 2201.
20. Hirano T., Ito Y., Koba S., Toyoda M., Ikejiri A., Saegusa H. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler. Thromb. Vasc. Biol. (2004) 24 558 563.
21. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. (1989) 6 67 75.
22. Ashton L.E., Fabien S.D., Madeleine J.B. Effect of meat replacement by Tofu on CHD risk factors including copper induced LDL oxidation. J. Am. College Nutr. (2000) 19 761 767.
23. De Geest B., Stengel D., Landeloos M. et al. Effect of overexpression of human apo A-1 in C57BL/6 and C57BL/6 apo-E deficient mice on 2 lipoprotein associated enzymes, platelet-activating factor acetylhydrolaseand paraoxonase. Comparison of adenovirus-mediated human apo A-1 gene transfer and human apo A-1 transgenics. Arteroiscle. Thromb. Vasc. Biol. (2000) 20 E68 E75.
24. El-Saddani M., Esterbauer H., Jurgens G.A. Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. (1989) 30 627 630.
25. Kunio Y. Assay for blood plasma or serum, in : Packer L. (Ed Methods in Enzymology, Academic Press, Orlando, Florida, 1984, pp. 328 331.
26. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care (2007) 30 8 13. PubMed
27. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care. (2002) 5 561 568.
28. Demirbag R., Yilmaz R., Gur M. et al. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int. J. Clin. Pract. (2006) 60 1187 1193.
29. Winterbone M.S., Sampson M.J., Saha S., Hughes J.C., Hughes D.A. Pro-oxidant effect of α-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test - a randomised controlled trial. Cardiovasc. Diabetol. (2007) 6 8. doi
30. Nishtha J., Naseem I., Ahmad J. Small dense LDL oxidation in hypertensives and diabetics and prediction of metabolic syndrome. Dia. Met. Syn. Clin. Res. Rev. (2008) 2 21 27.
31. Hamden K., Boujbiha M.A., Masmoudi H., Ayadi F.M., Jamoussi K., Elfeki A. Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed. Pharmacother. (2009) 63 95 99.
32. Grundy S.M. Jr., Brewer H.B., Cleeman J.I. Jr., Smith S.C., Lenfant C. National Heart, Lung, and Blood Institute, America Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. (2004) 24 e13 e18.
33. Shen B.J., Todaro J.F., Niaura R. et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am. J. Epidemiol. (2003) 157 701 711.
34. Carr A., Frei B. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic. Biol. Med. (2000) 28 1806 1814.
35. Ford E.S., Mokdad A.H., Giles W.H., Brown D.W. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes (2003) 52 2346 2352. PubMed
36. Damasceno D.C., Volpato G.T., Calderon I.M.P., Rudge M.V.C. Oxidative stress and diabetes in pregnant rats. Anim. Reprod. Sci. (2002) 72 235 244.
37. Parthiban A., Vijayalingam S., Shanmugasundaram K.R., Mohan R. Oxidative stress and the development of diabetic complications-antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol. Int. (1995) 19 987 993.
38. Bowry V.W., Mohr D., Cleary J., Stocker R. Prevention of tocopherol mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. (1995) 270 5756 5763
39. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic. Biol. Med. (1997) 22 57 71.
40. Packer L. Vitamin C and redox cycling antioxidants, in : Packer L., Fuchs J. (Eds Vitamin C in Health and Disease, Marcel Dekker Inc, New York, 1997, pp. 95 121.